Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

The Canadian Cancer Research Alliance (CCRA) is a collaboration of organizations funding cancer research in Canada to advance prevention, diagnosis, and treatment. Established in 2005, CCRA has grown to over 35 members and published strategic plans to enhance cancer research outcomes. The Alliance s

2 views • 40 slides

Pioneering cancer nurses in Europe are driving advancements in cancer care through innovative approaches, evidence-based knowledge, and personalized patient-centered care. They play a vital role in cancer prevention, healthcare policy enhancement, and education improvement. By putting patients and f

0 views • 12 slides

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides

The Canadian Cancer Statistics 2023 report provides a comprehensive analysis of cancer data, including trends, statistics, and insights for the year. The report covers various aspects of cancer, such as incidence rates, survival rates, types of cancers diagnosed, and advancements in cancer treatment

0 views • 31 slides

Dr. Manoj Dongare is one of the best colorectal cancer specialist in Pune which handles each and every case with utmost care. In his surgical experience, he performs many colorectal cancer surgeries successfully. His expertise in colorectal cancer surgery and surgical oncology makes him one of the b

0 views • 3 slides

The Cancer Therapy Evaluation Program (CTEP) aims to enhance cancer patients' lives by advancing cancer treatment through research and clinical trials. The Program includes a Protocol and Information Office (PIO) to streamline trial development processes. It funds national cancer research and focuse

0 views • 27 slides

This comprehensive guide explores the definitions, uses, and levels of screening and prevention in family medicine. It covers the criteria for screening tests, types of screening, examples of targeted populations, and approaches to preventing common problems in primary care. The content discusses th

0 views • 73 slides

Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag

0 views • 23 slides

Katie's journey with advanced colorectal cancer showcases the stark differences between a sub-optimal pathway, marked by delayed diagnosis, ineffective treatment, and inadequate palliative care, and an optimal pathway characterized by timely referrals, comprehensive support, and personalized care pl

2 views • 9 slides

Strong association of clinical biomarker - elevated DKK2 correlates with poor CRC prognosis. First-in-class therapeutic for colorectal cancer, targeting MSS CRC with multiple novel mechanisms of action and low risk for side effects. Complements current treatments like bevacizumab and shows efficacy

2 views • 11 slides

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides

This case study highlights Katie's journey through an advanced colorectal cancer care pathway, comparing a sub-optimal scenario with an ideal pathway. It emphasizes the importance of utilizing NHS RightCare methodology to enhance outcomes and value in healthcare delivery. The narrative reflects the

0 views • 14 slides

Bowel cancer, also known as colorectal cancer, is a significant health concern, being the fourth most common cancer in the UK. It is essential to be aware of the symptoms, risk factors, and preventive measures associated with this condition. By maintaining a healthy diet, managing body weight, and s

0 views • 9 slides

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

1 views • 11 slides

The FIT Pathway for suspected colorectal cancer aims to optimize referrals amidst reduced endoscopy availability due to the pandemic. By utilizing the Faecal Immunochemical Test (FIT) to triage patients, it allows for the prioritization of urgent cases, reducing the number of unnecessary colonoscopi

0 views • 34 slides

These pedigrees depict familial colorectal cancer syndromes in Ashkenazi and Iraqi Jews, showcasing early-onset MMR-proficient CRC cases linked to mutations in POLD1 and POLE genes. The pedigrees detail various cancer diagnoses, mutation carrier statuses, and ages of onset across multiple generation

0 views • 5 slides

The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in

0 views • 10 slides

The availability of colonoscopy has been impacted by the pandemic, leading to the adoption of Faecal Immunochemical Testing (FIT) for triaging suspected colorectal cancer referrals. Utilizing FIT results, negative patients are placed on a waiting list for later colonoscopy, allowing quicker assessme

0 views • 34 slides

This document outlines two projects conducted by the GI Collaborative Group focused on detecting and monitoring colorectal cancer using plasma protein markers and ctDNA/aberrantly methylated DNA markers. Project 1 aims to develop a panel of plasma biomarkers for the detection of adenomas and CRC, wh

0 views • 7 slides

Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e

0 views • 7 slides

Alcohol consumption is linked to an increased risk of various cancers, including mouth, throat, esophagus, breast, liver, and colorectal cancers. Factors such as ethanol, acetaldehyde, nutrient absorption, estrogen levels, and liver cirrhosis play a role in this risk. Even light drinking can elevate

0 views • 17 slides

The journey of cancer diagnosis brings forth various challenges, including misconceptions about nutrition. Debunking myths like soy stimulating cancer cells, sugar feeding cancer, and acidic diets curing cancer is crucial for informed decision-making. Evidence shows that soy can be a part of a healt

1 views • 11 slides

Lead by Catherine Neck, the Macmillan Cancer Rehabilitation/Recovery Package Project aims to enhance cancer care services. The Cancer Transformation Funding supports initiatives for breast, colorectal, and prostate cancers, including holistic needs assessments and wellbeing events. The SWAG Cancer A

0 views • 7 slides

The data presented showcases global cancer statistics from various years, highlighting the prevalence of different types of cancer across genders. It includes information on the estimated number of cancer cases, common types of cancers, and trends expected up to 2035. Lung cancer, breast cancer, and

0 views • 83 slides

The study focuses on young adults under 50 diagnosed with colorectal cancer in the Somerset, Wiltshire, Avon, and Gloucestershire regions. It aims to capture data on their epidemiology, diagnostic pathways, management, and outcomes from 2009 to 2019. The background and incidence trends both globally

0 views • 24 slides

The Washington State Colorectal Cancer Task Force met on March 3, 2023, with contributors Katie Treend, Mary Miller, Kayla Kenyon, Daniel Padron, Aden Afework, Sahla Suman, and Char Raunio. The agenda included introductions, history, brainstorming, and future plans, highlighting the Task Force's jou

0 views • 12 slides

Describes the successful integration of Complementary Medicine in the network of Cancer Departments within the Tuscan Public Healthcare System. The initiative, spearheaded by experts in both Complementary Medicine and medical oncology, has led to the development of Regional Guidelines incorporating

0 views • 4 slides

Blood tests for colorectal cancer (CRC) screening can enhance compliance and options for testing. Markers like ctDNA and aberrantly methylated genes provide potential for early detection and monitoring of CRC recurrence. By combining these markers in plasma samples processed similarly, a more effect

0 views • 36 slides

Cancer survival statistics in England, analyzed in collaboration between Public Health England (PHE) and the Office for National Statistics (ONS), provide crucial insights into the effectiveness of cancer services. These statistics measure the mortality rates of cancer patients and inform various st

0 views • 25 slides

Overview of bowel preparation regimens for colorectal cancer screening, emphasizing the importance of adequate bowel cleansing to enhance the effectiveness of colonoscopy. Highlights the impact of different dosing regimens on patient compliance, colon cleansing, and detection rates of small polyps.

0 views • 20 slides

Wyoming's colorectal cancer screening programs and awareness initiatives for February and March 2023 aim to educate and encourage early detection through regular screenings. Updates on program changes and resources, including healthy recipes and the 80% screening pledge, are emphasized. Various medi

0 views • 13 slides

Learn about the spending on various types of cancer in Europe including breast cancer, colorectal cancer, prostate cancer, lung cancer, ovary cancer, and pancreatic cancer. The information is based on the Comparator Report on Cancer in Europe 2019, which covers disease burden, costs, and access to m

1 views • 7 slides

DEBATECUP is a clinico-pathological syndrome encompassing various cancer types with occult primaries, each exhibiting predictable responses to therapies once classified. Current evidence supports CUP as a collection of specific cancer types with occult primary sites, posing challenges in primary sit

0 views • 12 slides

Exploring various aspects of colorectal disease and hernia, this overview covers symptoms, family history significance, approach to FHx issues, patient management based on FHx, new 2WW bowel cancer referral guidelines, and the use of faecal calprotectin as a marker. Detailed information provided by

0 views • 73 slides

Cytoplasmic expression of DCLK1-S, a novel isoform, is linked to tumor aggressiveness and poorer disease-specific survival in colorectal cancer. The study includes assessments of peptide conjugation, immunohistochemical staining in various tissues, and comparison of staining in colorectal cancer usi

0 views • 4 slides

This study details the adaptation of the Flu-FIT Program to enhance colorectal cancer screening rates within patient aligned care teams at the Veterans Affairs (VA) Department. By linking influenza immunization with colorectal cancer screening using fecal immunochemical testing, the project aimed to

0 views • 10 slides

This study examines the impact of the COVID-19 pandemic on colorectal, breast, and cervical cancer screening rates in safety-net primary care practices. A 7-year Quality Improvement Project aimed to increase screening rates through tailored education and practice facilitation. The project faced chal

0 views • 5 slides

Colorectal cancer, the 4th most common cancer in the UK, presents challenges in timely diagnosis and treatment due to capacity issues in diagnostic services. The SW CRC Pathway Case for Change highlights the need for redesigning pathways to improve patient experiences and outcomes. National initiati

0 views • 14 slides

The SWAG Cancer Services National Cancer Patient Experience Survey Results for 2021 provide insights into the experiences of skin cancer patients in Somerset, Wiltshire, Avon, and Gloucestershire. The survey, commissioned by NHS England, aims to monitor progress in cancer care, drive local quality i

0 views • 27 slides